References
- 1. Vickers A & Zollman C. Herbal medicine. (1999). Bmj. 319(7216), 1050-1053.
- 2. Kartal M. (2007). Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products. Phytother. Res. 21(2), 113-119.
- 3. De Abreu IN, Sawaya ACH, Eberlin MN & Mazzafera P. (2005). Production of pilocarpine in callus of jaboran- di (pilocarpus microphyllus stapf). In Vitro Cell. Dev. Biol. Plant. 41(6), 806-811.
- 4. Evans, WC. (2009). Trease and Evans’ pharmacognosy. Elsevier Health Sciences.
- 5. National policy on traditional medicine and regulation of herbal medicines: Report of a WHO global survey. (2005). World Health Organization, Geneva. Available to: http://whqlibdoc.who.int/publications/2005/9241593237.pdf
- 6. Li WF, Jiang JG & Chen J. (2008). Chinese medicine and its modernization demands. Arch. Med. Res. 39(2), 246-251.
- 7. Harrison RA, Holt D, Pattison DJ & Elton PJ. (2004). Who and how many people are taking herbal supplements? A survey of 21923 adults. Int. J. Vitam Nutr. Res. 74(3): 183-186.
- 8. Li JWH & Vederas JC. (2009). Drug discovery and natural products: end of an era or an endless frontier? Science. 325(5937), 161-165.
- 9. Sahoo N, P Manchikanti & Dey S. (2010). Herbal drugs: Standards and regulation. Fitoterapia. 81(6), 462-71.
- 10. Schmidt B, Ribnicky DM, Poulev A, Logendra S, Cefalu WT & Raskin, I. (2008). A natural history of botanical therapeutics. Metabolism. 57, S3-S9.
- 11. Barnes PM, Bloom B & Nahin R. (2008). Complementary and alternative medicine use among adults and children: United States: CDC National Health Statistics Report.
- 12. Moellering RC, Graybill JR, McGowan JE & Corey L. (2007). Antimicrobial resistance prevention initiativean update: Proceedings of an expert panel on resistance. Am. J. Infect. Control. 35(9), S1-S23.
- 13. Cohen ML. (1992). Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 257(5073), 1050-1055.
- 14. Sack RB, Rahman M, Yunus M & Khan EH. (1997). Antimicrobial resistance in organisms causing diarrheal disease. Clin. Infect. Dis. 24(Supplement 1), S102-S105.
- 15. Tekwu EM, Pieme AC & Beng VP. (2012). Investigations of antimicrobial activity of some Cameroonian medicinal plant extracts against bacteria and yeast with gastrointestinal relevance. J. Ethnopharmacol. 142(1), 265-273.
- 16. Cowan MM. (1999). Plant products as antimicrobial agents. Clin. MicrobioL. Rev. 12(4), 564-582.
- 17. Balunas MJ & Kinghorn AD. (2005). Drug discovery from medicinal plants. Life Sci. 78(5), 431-441.
- 18. Barbour EK, Al Sharif M, Sagherian VK, Habre AN, Talhouk RS & Talhouk SN. (2004). Screening of selected indigenous plants of Lebanon for antimicrobial activity. J. Ethnopharmacol. 93(1), 1-7.
- 19. McCutcheon AR, Ellis SM, Hancock REW & Towers GHN. (1992). Antibiotic screening of medicinal plants of the British Columbian native peoples. J. Ethnopharmacol. 37(3), 213-223.
- 20. Clardy J & Walsh C. Lessons from natural molecules. (2004). Nature. 432(7019), 829-837.
- 21. Freiesleben SH & Jager AK. (2014). Correlation between Plant Secondary Metabolites and Their Antifungal Mechanisms-A Review. J. Med. Arom. Pl. 3(2), 154.
- 22. Kumar VP, Chauhan NS, Padh H & Rajani M. (2006). Search for antibacterial and antifungal agents from selected Indian medicinal plants. J. Ethnopharmacol. 107(2), 182-188.
- 23. Arora DS, Kaur GJ. (2007). Antibacterial activity of some Indian medicinal plants. J. Nat. Med. 61(3), 313-317.
- 24. Ejim L, Farha MA., Falconer SB, Wildenhain J, Coombes BK, Tyers M, Brown ED & Wright GD. (2011). Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 7(6), 348-350.
- 25. Lin CM, Chen CS, Chen CT, Liang YC & Lin JK. (2002). Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem. Biophys. Res. Commun. 294(1), 167-172.
- 26. Saha MR, Hasan SMR, Akter R, Hossain MM, Alam MS, Alam MA & Mazumder MEH. (2008). In vitro free radical scavenging activity of methanol extract of the leaves of Mimusops elengi Linn. Bangladesh J. Vet. Med. 6(2), 197-202.
- 27. Pietta PG. (2000). Flavonoids as antioxidants. J. Nat. Prod. 63(7), 1035-1042.
- 28. Varon R, Garcia-Moreno M, Valera-Ruiperez D, Garcia- Molina F, Garcia-Canovas F, Ladron-de Guevara RG & Havsteen BH. (2006). Kinetic analysis of a general model of activation of aspartic proteinase zymogens. J. Theor. Biol. 242(3), 743-754.
- 29. Proteggente AR, Pannala AS, Paganga G, Buren LV, Wagner E, Wiseman S & Rice-Evans CA. (2002). The antioxidant activity of regularly consumed fruit and vegetables reflects their phenolic and vitamin C composition. Free Radical Res. 36(2), 217-233.
- 30. Lee SK, Mbwambo ZH, Chung H, Luyengi L, Gamez EJ, Mehta RG & Pezzuto JM. (1998). Evaluation of the antioxidant potential of natural products. Com. Chem. High T. Scr. 1(1), 35-46.
- 31. Vinson JA, Jang J, Dabbagh YA, Serry MM & Cai S. (1995). Plant polyphenols exhibit lipoprotein-bound antioxidant activity using an in vitro oxidation model for heart disease. J. Agr. Food Chem. 43(11), 2798-2799.
- 32. Fuhrman B, Volkova N, Rosenblat M & Aviram M. (2000). Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid. Redox Signal. 2(3), 491-506.
- 33. Halda JJ. Some taxonomic problems in the genus Daphne L. Acta Musei Richnoviensis Sect. Nat. 6 (3), 195-233.
- 34. Noshad D. (2007). Daphne Sudden Death Syndrome (DSDS): pathogen identification, characterization and screening for disease resistance. Kanada: The University of British Columbia.
- 35. Brickell CD & Mathew B. (1978). Daphne, The Genus in the Wild and in Cultivation: The Alpine Garden Society, Lye End Link, St. John’s, Woking GU21 1SW, Surrey.
- 36. Webb DA & Ferguson IK. (1968). Daphne In: Flora Europaea 2. Cambridge: Cambridge University Press.
- 37. Jušković, M, Vasiljević, P, Ranđelović, V, Stevanović, V & Stevanović, B. (2010). Comparative analysis of populations of the Balkan endemic species Daphne malyana Blečić (Thymeleaceae). Arch. Biol. Sci. 62(4), 1151-1162.
- 38. Xu WC, Shen JG & Jiang JQ. (2011). Phytochemical and biological studies of the plants from the genus Daphne. Chem. Biodivers. 8 (7), 1215-1233.
- 39. Cottigli F, Loy G, Garau D, Floris C, Caus M, Pompei R & Bonsignore L. (2001). Antimicrobial evaluation of coumarins and flavonoids from the stems of Daphne gnidium L. Phytomedicine. 8(4), 302-305.
- 40. Manojlović NT, Mašković PZ, Vasiljević PJ, Jelić RM., Jusković MŽ, Sovrlić M & Radojković M. (2012). HPLC Analysis, antimicrobial and antioxidant activities of Daphne cneorum L. Hem. Ind. 66(5), 709-716.
- 41. Sovrlić M, Vasiljević P, Jušković M, Mašković P & Manojlović N. (2015). Phytochemical, Antioxidant and Antimicrobial Profiles of Extracts of Daphne alpina (Thymelaeaceae) L Leaf and Twig from Mt Kopaonik (Serbia). Trop. J. Pharm. Res. 14(7), 1239-1248.
- 42. Niwa M, Sugino H, Takashima S, Sakai T, Wu C, Wu TS & Kuoh CS. (1991). A new coumarin glucoside from Daphne arisanensis. Chem. Pharm. Bull. 39, 2422-2424.
- 43. Hu XJ, Jin HZ, Su J, Zhang W, Xu WZ, Yan SK & Zhang WD. (2009). Coumarins from Daphne retusa. Chin. J. Nat. Med. 7, 34-36.
- 44. Mansoor F, Anis I, Ali S, Choudhary MI & Shah MR. (2013). New dimeric and trimeric coumarin glucosides from Daphne retusa Hemsl. Fitoterapia 2013; 88: 19-24.
- 45. Yeşilada E, Ustun O, Sezik E, Takaishi Y, Ono Y & Honda G. (1997). Inhibitory effects of Turkish folk remedies on inflammatory cytokines: interleukin-1α, interleukin-1β and tumor necrosis factor α. J. Ethnopharmacol. 58(1), 59-73.
- 46. Gu S & He J. (2012). Daphnoretin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells. Molecules. 17(1), 598-612.
- 47. Yuan H, Bi K, Chang W, Yue R, Li B, Ye J & Zhang W. (2014). Total synthesis of Daphnodorin A. Tetrahedron. 70(47), 9084-9092.
- 48. Yusa K, Oh-hara T, Tsukahara S, Baba K, Taniguchi M, Kozawa M & Tsuruo T. (1994). Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins. Antiviral Res. 25(1), 57-66.
- 49. Li S, Chou G, Hseu Y, Yang H, Kwan H & Yu Z. (2013). Isolation of anticancer constituents from flos genkwa (Daphne genkwa Sieb. et Zucc.) through bioassay-guided procedures. Chem. Cent. J. 7, 159.
- 50. Watanabe I, Yanai T, Awano KI, Kogami K & Hayashi K. (1983). Volatile components of Zinchoge flower (Daphne odora Thunb.). Agric. Biol. Chem. 47(3), 483-490.
- 51. Liang S, Shen YH, Feng Y, Tian JM, Liu XH, Xiong, Z & Zhang WD. (2010). Terpenoids from Daphne aurantiaca and their potential anti-inflammatory activity. J. Nat. Prod. 73(4), 532-535.
- 52. Huang SZ, Li XN, Ma QY, Dai HF, Li LC, Cai XH & Zhao YX. (2014). Daphnauranols A-C, new antifeedant sesqui terpenoids with a 5/6/7 ring system from Daphne aurantiaca. Tetrahedron Lett. 55(27), 3693-3696.
- 53. Hong JY, Nam JW, Seo EK & Lee SK. (2010). Daphnane diterpene esters with anti-proliferative activities against human lung cancer cells from Daphne genkwa. Chem. Pharm. Bull. 58(2), 234-237.
- 54. He W, Cik M, Appendino G, Puyvelde L, Leysen JE & Kimpe N. (2002). Daphnane-type diterpene orthoesters and their biological activities. Mini Rev. Med. Chem. 2(2), 185-200.
- 55. Inamori Y, Takeuchi K, Baba K & Kozawa M. (1987). Antifungal and insecticidal activities of daphnodorins A, B and C. Chem. Pharm. Bull. 35(9), 3931-3934.
- 56. Huang SZ, Zhang XJ, Li XY, Kong LM, Jiang HZ, Ma QY & Zhao YX. (2012). Daphnane-type diterpene esters with cytotoxic and anti-HIV-1 activities from Daphne acutiloba Rehd. Phytochemistry. 75, 99-107.
- 57. Jo SK, Hong JY, Par HJ & Lee SK. (2012). Anticancer activity of novel daphnane diterpenoids from Daphne genkwa through cell-cycle arrest and suppression of Akt/STAT/Src signalings in human lung cancer cells. Biomol. Ther. 20(6), 513.
- 58. Li ZJ, Li XM, Piao YJ, Choi DK, Kim SJ, Kim JW & Lee JH. (2014). Genkwadaphnin induces reactive oxygen species (ROS)-mediated apoptosis of squamous cell carcinoma (SCC) cells. Biochemical and biophysical research communications. 450(2), 1115-1119.
- 59. Katti SB & Tandon JS. (1979). Chemical Investigation on Daphne papyracea. Indian J. Chem., Sect. B. 18(2), 189-190.
- 60. Ulubelen A, Terem B & Tuzlacı E. (1986). Coumarins and Flavonoids from Daphne gnidioides. J. Nat. Prod. 49, 692-694.
- 61. Lin-gen Z, Seligmann O, Lotter H & Wagner H. (1983). (−)-Dihydrosesamin, a lignan from Daphne tangutica. Phytochemistry. 22(1), 265-267.
- 62. Pan L, Zhang XF, Deng Y, Zhou Y, Wang H & Ding LS. (2010). Chemical constituents investigation of Daphne tangutica. Fitoterapia. 81(1), 38-41.
- 63. Agnihotri S, Wakode S & Agnihotri A. (2010). An overview on anti-inflammatory properties and chemoprofiles of plants used in traditional medicine. Indian J. Nat. Prod. Resour. 1(2), 150-167.
- 64. Ullah N, Ahmad S & Malik A. (1999). Phenylpropanoid glycosides from Daphne oleoides. Chem. Pharm. Bull. 47, 114-115.
- 65. Yeşilada E, Taninaka H, Takaishi Y, Honda G, Sezik E, Momota H & Taki T. (2001). In vitro inhibitory effects of Daphne oleoides ssp. oleoides on inflammatory cytokines and activity-guided isolation of active constituents. Cytokine 2001. 13(6), 359-364.
- 66. Zhi-Wen WEI, Xiao-Wen GAO & Zheng WF. (2008). Anti-Tumor Activities of Total Flavonoids from the Roots of Daphne Genkwa. Pharmaceutical Journal of Chinese People’s Liberation Army 2008-2.
- 67. Park BY, Min BS, Oh SR, Kim JH, Bae KH & Lee HK. (2006). Isolation of flavonoids, a biscoumarin and an amide from the flower buds of Daphne genkwa and the evaluation of their anti-complement activity. Phytother. Res. 20(7), 610-613.
- 68. Zhang CF, Zhang SL, He X, Yang XL, Wu HT, Lin BQ & Yuan CS. (2014). Antioxidant effects of Genkwa flos flavonoids on Freund’ s adjuvant-induced rheumatoid arthritis in rats. J. Ethnopharmacol. 153(3), 793-800.
- 69. Da Yu Li CL, Jin Q, Lee JW, Lee MK & Hwang BY. (2014). A New Tigliane-Type Diterpenoid from Daphne genkwa. Notes. 35(2), 669.
- 70. Taniguchi M, Fujiwara A & Baba K. (1997). Three flavonoids from Daphne odora. Phytochemistry. 45(1), 183-188.
- 71. Taniguchi M, Fujiwara A, Baba K & Wang NH. (1998). Two biflavonoids from Daphne acutiloba. Phytochemistry. 49, 863-867.
- 72. Liang S, Xiong Z, Tian J & Zhang WD. (2011). Flavones from Daphne feddei. Chem. Nat. Compd. 47(5), 816-817.
- 73. Chaabane F, Boubaker J, Loussaif A, Neffati A, Kilani-Jaziri S, Ghedira K & Chekir-Ghedira L. (2012). Antioxidant, genotoxic and antigenotoxic activities of daphne gnidium leaf extracts. BMC Complement. Altern. Med. 12(1), 153.
- 74. Avicenna AB. The Canon of Medicine, Volume 2, Soroush Press, Tehran, pp: 214-215. (Translated by Sharafkandi in 1997)
- 75. Hu X, Jin H, Xu W, Zhang W, Liu X, Yan S & Zhang WD. (2008). Anti-inflammatory and analgesic effects of Daphne retusa Hemsl. J. Ethnopharmacol. 120 (1), 118-122.
- 76. Javidnia K, Miri R & Jahromi Rahim BNNK. (2003). A preliminary study on the biological activity of Daphne mucronata Royle. DARU Journal of Pharmaceutical Sciences. 11(1), 28-31.
- 77. Kupeli E, Tosun A & Yesilada E. (2007). Assessment of anti-inflammatory and antinociceptive activities of Daphne pontica L. (Thymelaeaceae). J. Ethnopharmacol. 113(2), 332-337.
- 78. Kupchan SM & Baxter RL. (1975). Mezerein: antileukemic principle isolated from Daphne mezereum L. Science. 187(4177), 652-653.
- 79. Fisher PB, Hermo JrH, Solowey WE, Dietrich MC, Edwalds GM, Weinstein IB & Kusama M. (1985). Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells. Anticancer Res. 6(4), 765-774.
- 80. Craker LE & Simon JEH. (1987). Species and Medicinal Plants: Recent Advances in Botany, Horticulture and Pharmacology Vol. 2. Canada: Oryx Press.
- 81. Xu X, Konirbay B & Jenis J. (2009). The Kazakh Materia Medica. Beijing: The Ethnic Press.
- 82. Kizaibek M, Daniar M, Li L & Upur H. (2011). Antiproliferative activity of different extracts from Daphne altaica Pall. on selected cancer cells. J. Med. Plants Res. 5(15), 3448-3452.
- 83. Basu NK & Nasipuri RN. (1962). A note on sedative and other constituents of Daphne papyraecea. Curr. Sci. 31(11), 463.
- 84. Zirvi KA. (1977). Isolation of daphnetin-8-betaglucoside from Daphne acuminata. Planta Med. 31(2), 119-122.
- 85. Manojlovic N, Sovrlic M, Maskovic P, Vasiljevic P & Juskovic M. (2014). Phenolic and Flavonoid Content and Antioxidant Activity of Daphne Blagayana Growing in Serbia. Ser. J. Exp. Clin. Res. 15(1), 21-27.
- 86. Sovrlić M, Vasiljević P, Jušković M, Mašković P & Manojlović N. (2014). Antimicrobial activity and HPLC analysis of Daphne blagayana L. (Thymelaeceae) extracts. Praxis medica. 43(4), 93-97.
- 87. Jochle W. (1974). Menses-inducing drugs: their role in antique, medieval and renaissance gynecology and birth control. Contraception. 10(4), 425-439.
- 88. Borris RP, Blasko G & Cordell GA. (1988). Ethnopharmacologic and phytochemical studies of the Thymelaeaceae. Journal of ethnopharmacology. 24(1), 41-91
- 89. Kariyone T & Koiso R. (1971). Atlas of medicinal plants (Vol. 150). Japan, p 83
- 90. Smith FP & Stuart GA. Chinese Medicinal Herbs, 1973 Georgetown Press. San Francisco, CA. pp. 44 -45,143 - 144,419 - 420.
- 91. Smith FP & Stuart GA. (1911). Chinese materia medica: Vegetable kingdom. American Presbyterian Mission Press. pp. 44-45,143- 144,460.
- 92. Ren CP. (1978). Long-acting local analgesic antidyne in anal operations. Chinese medical journal. 4(2), 158.
- 93. Cook EF & Martin EW. (1951). Remington’s Practice of Pharmacy. Remington’s practice of pharmacy. (10th Edit). pp. 274,740.
- 94. Claus EP. (1961) Pharmacognosy, 4th ed. Lea and Febiger, Philadelphia, PA. pp. 266-267.
- 95. Council of the Pharmaceutical Society of Great Britain (1958). The Extra Pharmacopoeia Martindale, Vol. 1, 24th ed. The Pharmaceutical Press, London, p. 1379.
- 96. Uphof JCT. (1959) Dictionary of Economic Plants. H.R. Engelmann, Winheim. pp. 30,121,123,138,172,1 79,206,209,267,382.
- 97. Lakin K.M. & Kosheleva, L.I. (1968). Daphnine action on blood coagulation. Farmakologqa i Toksikologito, Chemical Abstracts 31, 72- 74.
- 98. Schauenberg P. & Paris, F. (1977) Guide to Medicinal Plants, Keats Publishing, Inc., New Canaan, pp. 232-233.
- 99. Culpeper’s Complete Herbal (1818) Consisting of a Comprehensive Description of Nearly All Herbs With Their Medicinal Properties and Directions for Compounding the Medicines Extracted from Them. W. Foulsham and Co., Ltd., London, pp. 232- 233.
- 100. Biddle JB. (1896) Materia Medica and Therapeutics, 13th ed. P. Blakiston, Son and Co., Philadelphia, pp. 333-384.
- 101. Stuart, G.A. (1911) Chinese Mateti Medico, Vegetable Kingdom. American Presbyterian Mission Press, Shanghai, pp. 44-45,143- 144,460.
- 102. Kirtikar, K.R. and Basu, B.D. (1935) Indian Medicinal Plants, VoL III, 2nd ed. Lalit Mohan Basu, Allahabad, India, pp. 2167-2171.